Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Clinical trial NCT00673335 · COMPLETED

Trial details

NCT number: NCT00673335
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

brca1 Mutation Carrier brca2 Mutation Carrier Breast Cancer Hereditary Breast/Ovarian Cancer (brca1, brca2)

Start date: 2008-05-01
Primary completion: 2019-06-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.